Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mengting Gao
Institution:
Peking University Cancer Hospital
Observed institutions:
Sichuan University,
Peking University Cancer Hospital,
The First People's Hospital of Shuangliu District
ORCID:
0000-0003-1674-7187
Observed ORCID:
0000-0003-1674-7187
OpenAlex ID:
A5070375652
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
2022
·
Yanni Wang
, Jianling Zou
, et al.
·
Frontiers in Immunology
·
44
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer
2024
·
Mengting Gao
, Xueying Wu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
41
PDF
Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer
2022
·
Na Zhuo
, Chang Liu
, et al.
·
JAMA Network Open
·
33
PDF
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma
2024
·
Yanni Wang
, Chang Liu
, et al.
·
Signal Transduction and Targeted Therapy
·
23
Efficacy and safety of HER2-targeted inhibitors for metastatic colorectal cancer with HER2-amplified: A meta-analysis
2022
·
Mengting Gao
, Ting Jiang
, et al.
·
Pharmacological Research
·
12
Show more works
View as search
Works count:
5
Citation count:
153
H-index:
5
I10-index:
5
Year
Topic
Type